<VariationArchive VariationID="1351725" VariationName="NM_000027.4(AGA):c.187dup (p.Met63fs)" VariationType="Duplication" Accession="VCV001351725" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1486113" VariationID="1351725">
      <GeneList>
        <Gene Symbol="AGA" FullName="aspartylglucosaminidase" GeneID="175" HGNC_ID="HGNC:318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="177430774" stop="177442437" display_start="177430774" display_stop="177442437" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="178351927" stop="178363656" display_start="178351927" display_stop="178363656" Strand="-" />
          </Location>
          <OMIM>613228</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000027.4(AGA):c.187dup (p.Met63fs)</Name>
      <CanonicalSPDI>NC_000004.12:177440366:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="177440366" stop="177440367" display_start="177440366" display_stop="177440367" variantLength="1" positionVCF="177440366" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="178361520" stop="178361521" display_start="178361520" display_stop="178361521" variantLength="1" positionVCF="178361520" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>M63fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.178361521dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.178361521dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.177440367dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.177440367dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011845.2" sequenceAccession="NG_011845" sequenceVersion="2" change="g.7137dup">
            <Expression>NG_011845.2:g.7137dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000027.4" sequenceAccession="NM_000027" sequenceVersion="4" change="c.187dup" MANESelect="true">
            <Expression>NM_000027.4:c.187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000018.2" sequenceAccession="NP_000018" sequenceVersion="2" change="p.Met63fs">
            <Expression>NP_000018.2:p.Met63fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001171988.2" sequenceAccession="NM_001171988" sequenceVersion="2" change="c.187dup">
            <Expression>NM_001171988.2:c.187dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165459.1" sequenceAccession="NP_001165459" sequenceVersion="1" change="p.Met63fs">
            <Expression>NP_001165459.1:p.Met63fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033655.2" sequenceAccession="NR_033655" sequenceVersion="2" change="n.249dup">
            <Expression>NR_033655.2:n.249dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2111021738" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000027.4(AGA):c.187dup (p.Met63fs) AND Aspartylglucosaminuria" Accession="RCV002044945" Version="3">
        <ClassifiedConditionList TraitSetID="72">
          <ClassifiedCondition DB="MedGen" ID="C0268225">Aspartylglucosaminuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-12-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11309371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7627186</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="72" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="551" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Aspartylglycosaminuria</ElementValue>
                <XRef ID="Aspartylglucosaminuria/622" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aspartylglucos-aminuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aspartylglucos-amidase (AGA) deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycosylasparaginase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Aspartylglucosaminuria</ElementValue>
                <XRef ID="HP:0012068" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008830" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOASPARAGINASE</ElementValue>
                <XRef Type="MIM" ID="208400" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AGU</ElementValue>
                <XRef Type="MIM" ID="208400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5854" />
                <XRef ID="5854" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">38252773</ID>
                <ID Source="BookShelf">NBK599378</ID>
              </Citation>
              <XRef ID="93" DB="Orphanet" />
              <XRef ID="C0268225" DB="MedGen" />
              <XRef ID="MONDO:0008830" DB="MONDO" />
              <XRef Type="MIM" ID="208400" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012068" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4128878" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="12706692|MedGen:C0268225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002113036" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7627186</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11309371</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with AGA-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Met63Asnfs*3) in the AGA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGA are known to be pathogenic (PMID: 7627186, 11309371).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.178361520_178361521insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268225" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4128878" TraitType="Disease" MappingType="XRef" MappingValue="C0268225" MappingRef="MedGen">
        <MedGen CUI="C0268225" Name="Aspartylglucosaminuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

